Pharmacologic Cardioversion: A Medication-Based Approach
Pharmacologic cardioversion presents an alternative to electric shock therapy by utilizing medication to restore a normal heart rhythm. In this treatment method, healthcare professionals administer antiarrhythmia drugs to effectively regulate the heartbeat of their patients. The medication can be consumed orally or directly injected into the bloodstream through an intravenous (IV) route.
Risks Associated with Pharmacologic Cardioversion
When undergoing pharmacologic cardioversion, patients should be aware that there are certain risks involved. These risks include the possibility of experiencing more severe heart arrhythmias or an increased frequency of irregular heartbeats. In the event that these complications arise, physicians may opt to switch to a different medication or consider electrical cardioversion as an alternative.
Another risk associated with pharmacologic cardioversion is the potential to dislodge pre-existing blood clots from the heart. To mitigate this risk, healthcare providers may prescribe blood thinners prior to the procedure in order to minimize the chances of complications occurring.